Form 4: uniQure Director Sells Shares to Cover Tax Obligations Following RSU Vesting

uniQure N.V. Director Leonard E. Post sold 2,112 ordinary shares at a weighted average price of $14.45 to cover estimated withholding taxes upon the vesting of restricted share units.

Summary

• Leonard E. Post, a Director of uniQure N.V. (QURE), reported the sale of 2,112 ordinary shares.
• The transaction occurred on June 20, 2025.
• The shares were sold at a weighted average price of $14.45, with individual transactions ranging from $14.40 to $14.50.
• The sale was non-discretionary, executed automatically to cover estimated withholding taxes associated with the vesting of restricted share units.
• Following this transaction, Mr. Post directly beneficially owns 29,937 ordinary shares.

Sentiment

Score: 5

Explanation: The transaction is a non-discretionary sale for tax purposes, which is a routine event and does not indicate a change in the director's view of the company's prospects, thus maintaining a neutral sentiment.

Positives

• The sale was explicitly stated as non-discretionary and solely for the purpose of covering estimated withholding taxes, indicating it was not a reflection of a change in the director's confidence in the company's prospects.

Negatives

• A reduction in the director's direct shareholding, even if for tax purposes, results in a decrease in insider ownership.

Future Outlook

The document does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• "The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person."
• "The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.40 to $14.50. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."

Industry Context

This Form 4 filing details a routine insider transaction for tax purposes and does not provide information relevant to broader industry trends, competitive dynamics, or the overall market position of uniQure N.V. within the biotechnology or gene therapy sector.

Comparison to Industry Standards

• This document, an SEC Form 4, reports an individual insider transaction and does not contain information suitable for comparison to industry-wide financial or operational benchmarks, specific comparable companies, projects, or results.

Stakeholder Impact

• Shareholders: A minor reduction in a director's direct shareholding, but the non-discretionary nature for tax purposes mitigates concerns about insider sentiment.

Next Steps

• The Reporting Person undertakes to provide full information regarding the number of shares sold at each separate price within the reported range upon request from the Issuer, any shareholder, or the SEC staff.

Key Dates

Keywords

uniQure N.V., QURE, SEC Form 4, Insider Transaction, Director Share Sale, Restricted Share Units, Tax Withholding, Beneficial Ownership